Transvaginal laparoscopic cholecystectomy versus standard laparoscopic cholecystectomy

ISRCTN ISRCTN14307590
DOI https://doi.org/10.1186/ISRCTN14307590
Secondary identifying numbers N/A
Submission date
10/10/2008
Registration date
30/12/2008
Last edited
14/05/2013
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Klaus Gellert
Scientific

Sana Klinikum Berlin Lichtenberg
Fanninger Str 32
Berlin
10365
Germany

Study information

Study designProspective randomised controlled multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymTV-CCE
Study objectivesH0: There is no reduction of pain (NRS >=1) while resting or while coughing on the day of operation, on the first postoperative or on the second postoperative day with a transvaginal assisted cholecystectomy compared to a laparoscopic cholecystectomy.

H1: There is a reduction of pain (NRS>=1) while resting or while coughing on the day of operation, on the first postoperative or on the second postoperative day with a transvaginal assisted cholecystectomy compared to a laparoscopic cholecystectomy.

Please note that as of 14/05/2013, the anticipated end date for this trial was updated from 01/06/2010 to 12/06/2012
Ethics approval(s)Ethics Committee of Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) approved in April 2008 (ref: EA1/035/08).
Health condition(s) or problem(s) studiedCholecystolithiasis
Intervention1. Transvaginal cholecystectomy
2. Laparoscopic cholecystectomy
Intervention typeOther
Primary outcome measureReduction of pain, assessed with a numeric rating scale.

All outcomes will be assessed on the 7th and 28th postoperative day and 1 year after surgery.
Secondary outcome measures1. Wound infections
2. Trokar herniation
3. Morbidity
4. Mortality
5. Complications
6. Fatigue
7. Costs
8. Quality of life, assessed by a tool developed by Eypasch et al (1995) and SF-36 Health Survey
9. Long-term outcome

All outcomes will be assessed on the 7th and 28th postoperative day and 1 year after surgery.
Overall study start date01/06/2008
Completion date12/06/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants88
Key inclusion criteria1. Female
2. Full age (18 years or older)
3. Symptomatic cholecystolithiasis
Key exclusion criteria1. Male
2. <18 years
3. Patients desire for transvaginal/laparoscopic operation
4. Multiple adhesions
5. emergency
6. Acute cholecystitis
7. Choledocholithiasis
8. Malignoma
9. Acute vaginal infection
10. Gynaecological disease
11. Gravidity
12. Endometriosis
13. American Society of Anesthesiologists (ASA) IV
14. Liver disease (Child Pugh Criteria A, B, C)
Date of first enrolment01/06/2008
Date of final enrolment12/06/2012

Locations

Countries of recruitment

  • Germany

Study participating centre

Sana Klinikum Berlin Lichtenberg
Berlin
10365
Germany

Sponsor information

Sana Hospital Lichtenberg (Sana Klinikum Lichtenberg) (Germany)
Hospital/treatment centre

Fanninger Str 32
Berlin
10365
Germany

Website http://www.khl-berlin.de
ROR logo "ROR" https://ror.org/0071tdq26

Funders

Funder type

Hospital/treatment centre

Sana Hospital Lichtenberg (Sana Klinikum Lichtenberg) (Germany)

No information available

Olympus (Japan)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan